TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
BEAM

Beam Therapeutics Inc

Healthcare · Biotechnology

24.70$ +1.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement BEAM
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – +33.3% +215,916.7% +17.5% +520.0% -83.2% +120.0%
– +307,836.4% +61.2% +88.9% +125.0% +34.2% +40.4% -16.0% -93.9%
– – – – – – – -180.5% –
– +478.1% +61.2% +88.9% +275.2% -19.5% +40.4% -16.0% +11.4%
– +487.2% +73.2% +44.0% +93.3% +53.4% +33.0% -4.5% +2.1%
– +38.1% +73.2% +44.0% +616.7% -58.6% +531.2% -79.9% +349.4%
– – – – – – – – –
– – – +738.5% -99.4% +169,866.7% +205.1% +5.2% -10.9%
– – – – – – – – –
– -14,299.4% – +53,203.4% -147.4% – -59.9% -97.1% –
– – – – – – – – –
– – – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?